Skip to main content

Table 1 The timeline of the P. vivax attacks for the patient and antimalarial treatment

From: Multiple relapses of Plasmodium vivax malaria acquired from West Africa and association with poor metabolizer CYP2D6 variant: a case report

 

1st attack

2nd attack

3rd attack

4th attack

5th attack

Days from previous attack

0

58

113

88

232

Days from the 1st attack

0

58

171

259

491

Axillary temperature (°C) on admission

38.0

38.3

38.4

38.6

38.9

Symptomsa

R, H, B, C

R, H, B

R, H, B

R, H, B

R, H, B

Parasitemia (%) on admission

0.36

0.25

0.19

0.18

0.38

Treatmentb

CQ/PQ + AS (420 mg)

CQ/PQ + AS (660 mg); ACT1

CQ/PQ + AS (660 mg); ACT2

CQ/PQ; ACT2

AS (660 mg) + AZ (3500 mg); ACT2

Fever clearance time (h)

16

21

18.5

NA

23

  1. aSymptoms: R – rigor, H – headache, B – body aches, C – cough
  2. bDrug treatment: CQ/PQ – chloroquine (total 1200 mg base, 600 mg on day 1, 300 mg each on day 2 and 3)/primaquine (total 180 mg, 22.5 mg daily for 8 days), AS – artesunate at 12 h interval, ACT1 – artesunate-amodiaquine, ACT2 - dihydroartemisinin-piperaquine, AZ – azithromycin, NA – not available